China Pharmacy 2013 Issue 4 Effects of the Implementation of National Essential Drug System on Rational Use of Drugs in Community Health Service Center from Shanghai City

Effects of the Implementation of National Essential Drug System on Rational Use of Drugs in Community Health Service Center from Shanghai City
LUO Li 1;LI Wan-ying 1;LI Qiang 2;SHAO Yue-qin 2;SHEN Hong 2;CHEN Hai-le 1;ZHOU Yi-nan 1;ZHANG Ya-bing 3;NIU Xiao-qing 4;WANG Xiao-dong 4

..............page:289-291

Analysis of the Profit and Loss of Pharmaceutical Enterprises Caused by National Essential Drug System in Shanghai City
LI Wan-ying 1;SHAO Yue-qin 2;SHEN Hong 2;LI Qiang 2;CHEN Hai-le 1;ZHOU Yi-nan 1;ZHANG Ya-bing 3;WANG Xiao-dong 4;NIU Xiao-qing 4;LUO Li 1

..............page:291-293

Effect Evaluation and Consideration of Essential Drug System in Beijing Xicheng District around 6 Years before and after the Implementation of the System
SHI Ya-li;LI We

..............page:300-302

Analysis of Resolving the Problems of Shortage of Essential Drugs Based on the Perspective of Sale Terminals
XIE Xiao-dong;SHAO Rong

..............page:293-296

Research of Supervisory and Restraining Mechanism for Essential Drugs Manufacturers
HU Xia;HUANG Wen-long;MA Ai-xia

..............page:296-299

Investigation and Analysis of KAP Survey of Rational Drug Use under National Essential Drug System
YANG Zeng-guang

..............page:303-305

Analysis of Centralized Bidding and Purchasing of Essential Drugs in Guangdong Province in 2012
XIA Heng 1;2;MA Jian-chun 1;SHEN Yong-gang 1;CHEN Ji-sheng 1

..............page:316-319

Investigation and Analysis of the Implementation of National Essential Drug System in Division 4 of XPCC before and after Intervention
GAO Shan 1;MA Xiao-ming 2;LIU Juan 2

..............page:305-307

zhong guo yao fang za zhi gao yue

..............page:385-386

quan guo qu xiao yi yao bu yi li shun bu chang ji zhi zhuan ti yan tao hui yu bei tong zhi

..............page:388

Comparative Study on the Price and Availability of Essential Drugs in Public Hospital and Retail Pharmacy of Shaanxi Province
JIANG Ming-huan 1;WANG Le 1;WANG Wen-juan 1;WANG Xiao 1;FANG Yu 1;YANG Shi-min 1;ZHU Yan-bing 2;ZHANG Kang-huai 3

..............page:308-313

Exploration of Balance between Pharmaceutical Quality and Price during Drug Bidding
LI Jun 1;QIU Feng 2

..............page:319-321

Clinical Observation of Rosiglitazone on Level with Type 2 Diabetes Mellitus Polymorphism of the APN Gene
ZHAO Hai-yan;TIAN Ping;CHEN Li-bo;ZHANG Chang-ning;YE Qiang;ZHANG Hong-l

..............page:322-324

Analysis of the Losing Bidding Drug in the Centralized Bidding of Essential Drugs in 8 Provinces and Autonomous Region in 2011
MA Jian-chun 1;XIA Heng 2;SHEN Yong-gang 1;CHEN Ji-sheng 1

..............page:313-315

Comparison of the Efficacy of 2 Different Regimens for Patients with HAART-associated Dyslipidemia
SU Qi-jian 1;LIANG Fei-li 2;LI Yi-zhong 1;DENG Xin 1;DENG Mei-hua 2;ZHANG Ya-ping 1

..............page:332-334

guo jia shi pin yao pin jian du guan li ju fu ju chang jiao hong fu tian jin diao yan yi liao qi xie jian guan gong zuo

..............page:299

Effect of Levocarnitine on Carnitine Set of Patients with Dilated Cardiomyopathy
LI Sheng-nan 1;2;JING Fan-bo 3;XIA Yun-qiu 1;GUO Lin-lin 2;SUN Zhen-long 4;HAN Zhi-wu 3;SUI Zhong-guo 3;WANG Chun-bo 1

..............page:325-328

Evaluation of Influence of National Essential Drug System on Rational Use of Antibacterials in Community from Beijing Area during 2009-2011
CHANG Li-jie 1;ZHAO Zhi-gang 2;SONG Xiao-jing 3;XU Zhong-miao 1;WU Hao 1

..............page:335-338

wei sheng bu dang zu shu ji fu bu chang zhang mao fu gui zhou diao yan yi gai gong zuo

..............page:334

Cost-effectiveness Analysis of Thymopentin Combined with TP Regimen in the Treatment of Advanced Non-small Cell Lung Cancer
LI Yu-ping 1;ZHANG Xiao-qing 1;HU Ping 1;LI Yi-qian 1;NI Jian 2

..............page:329-332

gao wei yao pin yu yong yao an quan yan tao hui zuo zhong guo yi yao bao kan xie hui yong yao an quan xin xi zhuan ye wei yuan hui cheng li da hui zai jing zhao kai
shi guang

..............page:351

Clinical Observation of Aerosol Inhalation of Salbutamol Combined with Huangqi Injection in the Treatment of Chronic Obstructive Pulmonary Disease
GAO Shao-lin;XIAO Hong

..............page:338-339

xi bu ling shou yao dian yao pin dian zi jian guan shi dian xiang mu qian yue yi shi zai wu han ju xing

..............page:373

Clinical Observation of Pramipexole Combined with Levodopa for Parkinson’s Disease
DENG Qiang;LI Ying-hui;QIN Yu

..............page:347-349

Efficacy Observation of Enema Therapy of Lactulose and White Vinegar Diluted Solution in the Treatment of Early Hepatic Coma
XIAO Zheng 1;YIN Xiong-zhang 2

..............page:340-342

Comparison of Therapeutic Efficacy of Ursodesoxycholic Acid or Tauro-ursodesoxycholic Acid Combined with Polyene Phosphatidylcholine for Non-alcohol Fatty Liver Disease
CAO Rong 1;HU Xu-dong 1;BAI Tao 1;CHENG Hai-lin 1;GAN Hong-ying 1;HUANG Shao-ping 1;WANG Ying-fu 2

..............page:365-367

Cohort Study on Therapeutic Efficacy of SXT and SXN Injection in the Treatment of Acute Ischemic Stroke
LIU Jing 1;2;LIU Fang 1;ZHAI Suo-di 1

..............page:349-351

Efficacy Observation of Compound Sophora flavescens Injection Combined with Lamivadine on Chronic Hepatitis B Cirrhosis
CHEN Gang;MAO Jie;JIAO Zuo-yi;LI Yu-min

..............page:342-344

Analysis of 63 Cases of Cardiac Adverse Reactions Induced by Calcium Antagonists in Guangdong Province
LI Xun 1;LIU Qiu-qiong 1;CHEN Wen-ying 1;HUANG Li-lin 2;LIN Qiu-xiao 1;TAN Shu-min 1

..............page:367-369

Analysis of Simvastatin-induced Adverse Drug Reactions between 2007 and 2011 in Beijing
JI Li-wei 1;XING Li-qiu 2;ZHOU Bing 2;ZHANG Li-ming 2

..............page:370-373

Cohort Study of Dosing Interval and ADR Incidence of Infusion in Medical Institutions of Tianjin City
ZHU Li-qin 1;XU Yan-gui 1;DU Yi 2;WANG Dong-fei 3

..............page:352-353

Clinical Observation of 99 Technetium Methylenediphosphonate Combined with Calcium and Vitamin D₃ in the Treatment of the Change of Bone Metabolism Markers Caused by Primary Osteoporosis（Type Ⅰ）
ZHENG Fei-bo;WANG Ming-min;LIU Bing-ji;ZHU Wen-ru;LIANG Jie;YU Hua

..............page:345-346

Efficacy and Safety of Statins in the Treatment of Normolipidemic Patients with Isolated Systolic Hypertension:a Meta-analysis
WEI Xiao-chen 1;2;ZHU Li-qin 2;CHEN Fan 2

..............page:354-359

Content Determination of Catalpol in Zuogui Pills by HPLC
SUN Lin-lin 1;REN Yan-hai 2;CHEN Hai-ling 3;LU Lin 1;LIU Yan-qiu 1

..............page:374-375

Verification of the Method for the Content Determination of Simvastatin Tablets by HPLC
SHEN Jian-fei;QU Feng-ping

..............page:376-377

ta ting lei yao wu de lin chuang duo xiao xing yan jiu jin zhan
yang dong mei yuan bai yang

..............page:378-382

Tamoxifen for Polycystic Ovarian Syndrome:a Systematic Review
WANG Ai-hua 1;TANG Hui-lin 2;FENG Xin 1

..............page:359-362

Innovation Practice of “Three Actualization+One Enterprization” Talents Training Mode for Pharmaceutical Preparation Technology
PAN Wei-dong;CHEN Chun;XUE Ying-ying;ZHAO Yan-ling

..............page:382-384

Discussion on the Concentration and Preparation Method of Tetanus Antitoxin Skin Test Solution
XIANG Hong-yu;MU Fa-xu;TANG Xiao-bin;MIN Ran-xing;YAN Jun-feng

..............page:363-365